Jens Juul Holst
Jens Juul Holst publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Endocrine and Autonomic Systems, on topics such as Diabetes Treatment and Management, Pancreatic function and diabetes and Neuropeptides and Animal Physiology.
- World rank
- #7,387,573 of 7,710,434 ranked researchers
- Rank in Denmark
- #43,018 of 43,819
- Works
- 155
- Citations
- 36
- Citations per work
- 0.2
What does Jens Juul Holst research?
Jens Juul Holst's work is mostly in Medicine (45%), Neuroscience (18%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7045.4%
- Medicine7045.4%
- Everything else4629.5%
- Life Sciences3925.1%
- 1Endocrinology, Diabetes and Metabolism29% of their works
- 2Surgery14% of their works
- 3Endocrine and Autonomic Systems9% of their works
- 4Cellular and Molecular Neuroscience9% of their works
- 5Molecular Biology7% of their works
- 6Physiology3% of their works
Research topics
- Diabetes Treatment and Management
- Pancreatic function and diabetes
- Neuropeptides and Animal Physiology
- Regulation of Appetite and Obesity
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Metabolism, Diabetes, and Cancer
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Bariatric Surgery and Outcomes
Which keywords describe Jens Juul Holst's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Cardiovascular Outcomes, Glucose Control, Diabetes Mellitus, Obesity and Pancreatic Islets.
- Metabolic Surgery
- Bariatric Surgery
- AMP-Activated Protein Kinase
- Critical Care
- Diabetes
- Ghrelin
- Neuropeptides
- Pancreatic Islets
- Diabetes Mellitus
- Cardiovascular Outcomes
- Insulin Therapy
- Glycemic Control
- Type 2 Diabetes
- Glucose Control
- Obesity
- ß-Cell Dysfunction
- Receptors
- Leptin
- Lifestyle Intervention
- Hyperglycemia
- Metformin
- Cardiovascular Disease
- Metabolic Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Glycemic Control1022 topics
- Insulin Therapy1022 topics
- Type 2 Diabetes962 topics
- Cardiovascular Outcomes861 topic
- Glucose Control861 topic
- Diabetes Mellitus552 topics
- Obesity553 topics
- Pancreatic Islets391 topic
- ß-Cell Dysfunction391 topic
- Neuropeptides371 topic
- Receptors371 topic
- Ghrelin351 topic
- Leptin351 topic
- Diabetes202 topics
- Lifestyle Intervention202 topics
- Critical Care161 topic
- Hyperglycemia161 topic
- AMP-Activated Protein Kinase121 topic
- Metformin121 topic
- Bariatric Surgery101 topic
- Cardiovascular Disease101 topic
- Metabolic Surgery101 topic
- Metabolic Syndrome101 topic
Where does Jens Juul Holst work?
Jens Juul Holst's main affiliation in the publication record is Novo Nordisk Foundation, Denmark.
How many publications and citations does Jens Juul Holst have?
OpenAlex counts 155 works and 36 citations for Jens Juul Holst, an h-index of 3, ranking #7,387,573 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Jens Juul Holst
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jens Juul Holst. Posts are plain text and can be reported.